Dilapan-S / Dilasoft E-Registry in Induced Abortion
Launched by MEDICEM INTERNATIONAL CR S.R.O. · Dec 11, 2014
Trial Information
Current as of August 02, 2025
Completed
Keywords
ClinConnect Summary
International, multicentre, non-interventional, observational e-registry, post market clinical follow up study to document current clinical use of Dilapan-S or Dilasoft for cervical priming before induced abortion with regard to the number of dilators used, duration of insertion of dilators in situ and unusual complications consequent of their use.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Intrauterine pregnancy ≥ 6 and ≤ 24 weeks gestation
- • Patients who are capable of giving consent and sign the form
- • Abortion being made in compliance with the Abortion Act 1967 (For England, Wales and Scotland)
- Exclusion Criteria:
- • Clinical signs of uterine, vaginal or vulvar infection
- • Acute bleeding
About Medicem International Cr S.R.O.
Medicem International CR s.r.o. is a leading clinical trial sponsor specializing in the development and management of innovative therapies across various therapeutic areas. With a commitment to advancing healthcare through rigorous scientific research, Medicem International CR s.r.o. collaborates with healthcare professionals and regulatory bodies to ensure the highest standards of patient safety and data integrity. The organization leverages its extensive expertise in clinical operations and regulatory compliance to facilitate the efficient conduct of clinical trials, ultimately aiming to bring novel treatments to market that improve patient outcomes and enhance the quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Patricia Lohr, MD
Principal Investigator
British Pregnancy Advisory Service, UK
Jiri Hanacek, MD
Principal Investigator
Institute of Care for Mother and Child, Prague, CZ
Natalia Kan, Prof., MD
Principal Investigator
Research Center for Obstetrics, Gynecology and Perinatology, Moscow
John Roizin, MD
Principal Investigator
Allentown Women´s Center, Bethlehem, PA, US
Mary Jane Bovo, MD
Principal Investigator
Choices Women´s Medical Center, New York
LeRoy Carhart, MD
Principal Investigator
Germantown Reproductive Health Service
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials